Treace Long Term Debt vs Total Stockholder Equity Analysis

TMCI Stock

USD 4.69 0.24 4.87%

Treace Medical financial indicator trend analysis is much more than just breaking down Treace Medical Concepts prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Treace Medical Concepts is a good investment. Please check the relationship between Treace Medical Long Term Debt and its Total Stockholder Equity accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Treace Medical Concepts. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Long Term Debt vs Total Stockholder Equity

Long Term Debt vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Treace Medical Concepts Long Term Debt account and Total Stockholder Equity. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Treace Medical's Long Term Debt and Total Stockholder Equity is 0.82. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Treace Medical Concepts, assuming nothing else is changed. The correlation between historical values of Treace Medical's Long Term Debt and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Treace Medical Concepts are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Long Term Debt i.e., Treace Medical's Long Term Debt and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.82

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Long Term Debt

Long-term debt is a debt that Treace Medical Concepts has held for over one year. Long-term debt appears on Treace Medical Concepts balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Treace Medical Concepts balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most indicators from Treace Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Treace Medical Concepts current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Treace Medical Concepts. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

The Treace Medical's current Enterprise Value is estimated to increase to about 1.3 B, while Selling General Administrative is projected to decrease to under 24.1 M.

	2022	2023	2024 (projected)
Depreciation And Amortization	4.7M	5.4M	2.8M
Interest Income	910K	5.4M	5.6M

Depreciation And Amortization Interest Income

Treace Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets
Total Assets		0.92	0.96	0.98	0.91	0.9	0.86	0.34	-0.91	0.98	0.32	0.84	0.44	0.93	0.97	0.98	0.99	0.92	0.92	0.97	0.9	0.92	0.95	1.0	0.86	0.99
Short Long Term Debt Total	0.92		0.89	0.96	0.79	0.75	0.92	0.59	-0.91	0.98	0.06	0.85	0.69	1.0	0.84	0.98	0.95	0.86	1.0	0.96	0.84	0.85	0.99	0.89	0.89	0.9
Other Current Liab	0.96	0.89		0.95	0.85	0.82	0.87	0.43	-0.89	0.95	0.17	0.83	0.5	0.88	0.9	0.94	0.97	0.89	0.9	0.95	0.86	0.87	0.93	0.94	0.85	0.93
Total Current Liabilities	0.98	0.96	0.95		0.87	0.81	0.9	0.5	-0.93	1.0	0.15	0.88	0.59	0.96	0.92	1.0	0.98	0.92	0.96	1.0	0.89	0.9	0.99	0.96	0.89	0.96
Total Stockholder Equity	0.91	0.79	0.85	0.87		0.85	0.88	0.32	-0.94	0.86	0.34	0.9	0.4	0.82	0.92	0.87	0.86	0.97	0.79	0.85	0.98	0.99	0.83	0.92	0.9	0.92
Net Tangible Assets	0.9	0.75	0.82	0.81	0.85		0.66	-0.04	-0.73	0.81	0.67	0.61	0.07	0.78	0.97	0.81	0.9	0.76	0.75	0.77	0.74	0.8	0.78	0.93	0.64	0.94
Property Plant And Equipment Net	0.86	0.92	0.87	0.9	0.88	0.66		0.7	-0.98	0.91	-0.07	0.98	0.77	0.91	0.78	0.91	0.86	0.95	0.92	0.91	0.95	0.94	0.92	0.83	0.99	0.84
Net Debt	0.34	0.59	0.43	0.5	0.32	-0.04	0.7		-0.61	0.51	-0.75	0.69	0.99	0.54	0.14	0.51	0.36	0.52	0.59	0.54	0.51	0.45	0.56	0.26	0.7	0.26
Retained Earnings	-0.91	-0.91	-0.89	-0.93	-0.94	-0.73	-0.98	-0.61		-0.93	-0.04	-0.99	-0.68	-0.91	-0.85	-0.94	-0.89	-0.99	-0.9	-0.93	-0.99	-0.98	-0.92	-0.89	-0.99	-0.89
Accounts Payable	0.98	0.98	0.95	1.0	0.86	0.81	0.91	0.51	-0.93		0.14	0.87	0.6	0.98	0.91	1.0	0.98	0.91	0.98	0.99	0.88	0.89	1.0	0.95	0.89	0.95
Cash	0.32	0.06	0.17	0.15	0.34	0.67	-0.07	-0.75	-0.04	0.14		-0.09	-0.66	0.12	0.52	0.15	0.29	0.12	0.06	0.09	0.13	0.21	0.1	0.4	-0.08	0.41
Non Current Assets Total	0.84	0.85	0.83	0.88	0.9	0.61	0.98	0.69	-0.99	0.87	-0.09		0.74	0.84	0.76	0.88	0.8	0.97	0.85	0.88	0.98	0.95	0.87	0.81	0.99	0.81
Non Currrent Assets Other	0.44	0.69	0.5	0.59	0.4	0.07	0.77	0.99	-0.68	0.6	-0.66	0.74		0.65	0.25	0.6	0.46	0.59	0.68	0.63	0.58	0.53	0.65	0.36	0.76	0.36
Long Term Debt	0.93	1.0	0.88	0.96	0.82	0.78	0.91	0.54	-0.91	0.98	0.12	0.84	0.65		0.87	0.98	0.95	0.87	1.0	0.96	0.85	0.86	0.99	0.9	0.88	0.91
Cash And Short Term Investments	0.97	0.84	0.9	0.92	0.92	0.97	0.78	0.14	-0.85	0.91	0.52	0.76	0.25	0.87		0.91	0.95	0.87	0.84	0.89	0.86	0.9	0.88	0.99	0.77	0.99
Net Receivables	0.98	0.98	0.94	1.0	0.87	0.81	0.91	0.51	-0.94	1.0	0.15	0.88	0.6	0.98	0.91		0.98	0.92	0.98	0.99	0.89	0.9	0.99	0.96	0.9	0.96
Common Stock Total Equity	0.99	0.95	0.97	0.98	0.86	0.9	0.86	0.36	-0.89	0.98	0.29	0.8	0.46	0.95	0.95	0.98		0.88	0.95	0.97	0.85	0.88	0.97	0.98	0.84	0.98
Common Stock Shares Outstanding	0.92	0.86	0.89	0.92	0.97	0.76	0.95	0.52	-0.99	0.91	0.12	0.97	0.59	0.87	0.87	0.92	0.88		0.86	0.92	1.0	0.99	0.89	0.91	0.97	0.91
Non Current Liabilities Total	0.92	1.0	0.9	0.96	0.79	0.75	0.92	0.59	-0.9	0.98	0.06	0.85	0.68	1.0	0.84	0.98	0.95	0.86		0.96	0.84	0.85	0.99	0.89	0.89	0.9
Inventory	0.97	0.96	0.95	1.0	0.85	0.77	0.91	0.54	-0.93	0.99	0.09	0.88	0.63	0.96	0.89	0.99	0.97	0.92	0.96		0.89	0.89	0.98	0.94	0.9	0.94
Other Current Assets	0.9	0.84	0.86	0.89	0.98	0.74	0.95	0.51	-0.99	0.88	0.13	0.98	0.58	0.85	0.86	0.89	0.85	1.0	0.84	0.89		1.0	0.87	0.89	0.97	0.89
Other Stockholder Equity	0.92	0.85	0.87	0.9	0.99	0.8	0.94	0.45	-0.98	0.89	0.21	0.95	0.53	0.86	0.9	0.9	0.88	0.99	0.85	0.89	1.0		0.88	0.92	0.95	0.92
Total Liab	0.95	0.99	0.93	0.99	0.83	0.78	0.92	0.56	-0.92	1.0	0.1	0.87	0.65	0.99	0.88	0.99	0.97	0.89	0.99	0.98	0.87	0.88		0.93	0.9	0.93
Net Invested Capital	1.0	0.89	0.94	0.96	0.92	0.93	0.83	0.26	-0.89	0.95	0.4	0.81	0.36	0.9	0.99	0.96	0.98	0.91	0.89	0.94	0.89	0.92	0.93		0.83	1.0
Property Plant And Equipment Gross	0.86	0.89	0.85	0.89	0.9	0.64	0.99	0.7	-0.99	0.89	-0.08	0.99	0.76	0.88	0.77	0.9	0.84	0.97	0.89	0.9	0.97	0.95	0.9	0.83		0.83
Total Current Assets	0.99	0.9	0.93	0.96	0.92	0.94	0.84	0.26	-0.89	0.95	0.41	0.81	0.36	0.91	0.99	0.96	0.98	0.91	0.9	0.94	0.89	0.92	0.93	1.0	0.83

Click cells to compare fundamentals

Treace Medical Account Relationship Matchups

Currently Active Assets on Macroaxis

MSFT	Microsoft
V	Visa Class A
MSFT	Microsoft
BAC	Bank of America
CRM	Salesforce

When determining whether Treace Medical Concepts offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Treace Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Treace Medical Concepts Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Treace Medical Concepts Stock:

How To Invest In Treace

Details

Is Treace Stock a good investment?

Details

What is Treace Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Treace Medical Concepts. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.02)

Revenue Per Share

3.213

Quarterly Revenue Growth

0.06

Return On Assets

(0.17)

Return On Equity

(0.49)

The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Treace Long Term Debt vs Total Stockholder Equity Analysis

Long Term Debt vs Total Stockholder Equity

Long Term Debt vs Total Stockholder Equity Correlation Analysis

Correlation Coefficient

Long Term Debt

Total Stockholder Equity

Treace Medical fundamental ratios Correlations

Treace Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Invested Capital	+ 1.0	Total Assets
Long Term Debt	+ 1.0	Short Long Term Debt Total
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Accounts Payable	+ 1.0	Total Current Liabilities
Net Receivables	+ 1.0	Total Current Liabilities
Inventory	+ 1.0	Total Current Liabilities

Property Plant And Equipment Gross	- 0.99	Retained Earnings
Other Current Assets	- 0.99	Retained Earnings
Common Stock Shares Outstanding	- 0.99	Retained Earnings
Non Current Assets Total	- 0.99	Retained Earnings
Other Stockholder Equity	- 0.98	Retained Earnings
Retained Earnings	- 0.98	Property Plant And Equipment Net